Analysts Offer Insights on Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP), Ionis Pharmaceuticals (IONS) and Zura Bio (ZURA)

TipRanksDec 25, 2024 06:51 ET · Ratings

Cautious Hold Rating on Zura Bio Due to Efficacy Concerns and Competitive Risks

TipRanksDec 24, 2024 06:15 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Neutral on Zura Bio, Maintains $5 Price Target

BenzingaDec 24, 2024 06:13 ET

Zura Bio Begins Phase 2 Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis

MT NewswiresDec 23, 2024 09:51 ET

Express News | Zura Bio Launches Global Phase 2 Tibusure Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis

ReutersDec 23, 2024 06:44 ET

Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis

BusinesswireDec 23, 2024 06:30 ET